The most important financial indicators for the company Novel Research S.r.l. - Unique Identification Number 17012794:
sales in 2023 was
898.944
euro, registering a net profit of
147.032
euro and having an average number of
6
employees.
Firma isi desfasoara activitatea in domeniul Activitati de studiere a pietei si de sondare a opiniei publice having the NACE code 7320.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 58.9%, from 567.349 euro in the year 2022, to 898.944 euro in 2023.
The Net Profit increased by 48.437 euro, from 98.895 euro in 2022, to 147.032 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novel Research S.r.l. - CUI 17012794
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
18.544
10.476
5.339
5.666
28.837
8.509
5.935
7.590
6.848
8.823
Current Assets
180.388
266.727
308.264
261.351
602.522
400.116
604.389
394.798
234.064
432.906
Inventories
2.545
2.706
2.619
5.647
4.277
1.300
3.391
1.071
2.773
1.832
Receivables
103.528
53.885
77.842
91.832
413.714
175.303
290.522
163.439
137.501
233.251
Cash
74.315
210.136
227.804
163.871
184.531
223.513
310.475
230.287
93.790
197.823
Shareholders Funds
117.527
160.713
155.804
105.140
265.924
151.354
331.496
119.702
150.078
198.060
Social Capital
45
45
62
61
60
59
58
57
57
57
Debts
81.442
116.489
161.917
162.407
372.067
272.247
283.434
285.705
94.222
244.043
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7320 - 7320"
CAEN Financial Year
7320
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
432.906 euro in 2023 which includes Inventories of
1.832 euro, Receivables of
233.251 euro and cash availability of
197.823 euro.
The company's Equity was valued at
198.060 euro, while total Liabilities amounted to
244.043 euro.
Equity increased by 48.437 euro, from 150.078 euro in 2022, to 198.060 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novel Research S.r.l.